Rural heart failure patients fare better at urban hospitals, but still trail urban patients: Study 

Advertisement

Rural patients hospitalized at urban hospitals for heart failure with reduced ejection fraction receive more cardiology consultations and guideline-directed medical therapy, a study found. 

The study, published Oct. 30 in JAMA Cardiology, analyzed data on 735,460 Medicare fee-for-service beneficiaries discharged alive after a hospitalization for heart failure with reduced ejection fraction between 2013 and 2021. Researchers sorted patients into four groups: rural patients in rural hospitals (9.4%), rural patients in urban hospitals (8.9%), urban patients in urban hospitals (79.3%), and urban patients in rural hospitals (2.4%).

Here are four findings:

1. Rural patients treated at urban hospitals had about twice the odds of receiving an inpatient cardiology consultation compared with rural patients at rural hospitals. Ninety days after discharge, they were also more likely to be taking all four major classes of heart failure drugs, including beta-blockers and SGLT2 inhibitors. However, gains in reaching at least half the target doses were inconsistent.  

2. Rural patients treated at urban hospitals had lower rates of heart failure readmission and death at all time points, but they were less likely to complete outpatient follow-up within 14 days. 

3. Among patients treated at urban hospitals, rural patients were more likely than urban patients to receive inpatient cardiology consultation and had lower heart failure readmission at one year. The authors said the lower readmission rate may reflect barriers to accessing care rather than better clinical stability. 

4. Rural patients treated at urban hospitals had higher mortality at 30 and 90 days than urban patients treated at the same urban hospitals, with no significant difference at one year. This suggests the early risk of decompensation after heart failure hospitalization may be worse for rural patients due to factors such as social determinants of health, delayed follow-up and medication affordability, according to the study authors.

Advertisement

Next Up in Cardiology

Advertisement